Alogliptin/Metformin (Kazano): Uses, Side Effects, Interactions, Pictures, Warnings & Dosing – WebMD

Kazano is a prescription combo pill used for type 2 diabetesand it’s basically a “two-tools-in-one” approach: alogliptin (a DPP-4 inhibitor) plus metformin (a biguanide). One helps your body make better use of its own insulin signals, and the other helps lower glucose production and improve insulin sensitivity. Together, they aim to lower blood sugar without asking you to carry two separate bottles like a traveling pharmacy.

That said: diabetes meds are not “set it and forget it.” Kazano comes with important safety warnings (including a boxed warning related to metformin) and isn’t right for everyone. This guide explains what it’s for, how it’s taken, what to watch for, and how to avoid the most common “wait… can I take this with that?” moments.

Quick Snapshot (For People Who Like the Highlights)

• What it treats: Type 2 diabetes (not type 1, not diabetic ketoacidosis)
• What it contains: Alogliptin + metformin
• How it’s usually taken: Twice daily with food
• Main goals: Improve A1C and daily blood sugar (with diet/exercise)
• Biggest “pay attention” warning: Metformin-associated lactic acidosis (rare, but serious)

What Is Kazano, Exactly?

Kazano is a fixed-dose combination of:

• Alogliptin: A DPP-4 inhibitor that increases incretin hormones, helping your body release insulin when glucose is high and reducing glucagon (a hormone that raises glucose).
• Metformin: Helps reduce glucose made by the liver and improves insulin sensitivity, often considered a cornerstone medication for type 2 diabetes.

Because it’s a combo pill, Kazano is often considered when a clinician decides that both medications are appropriate at the same timeeither because one medicine isn’t enough or because a person was already taking both separately and wants a simpler regimen.

Uses: Who Is Kazano For?

Approved use

Kazano is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes when treatment with both alogliptin and metformin is appropriate.

Not for

• Type 1 diabetes
• Diabetic ketoacidosis (DKA) (this requires insulin-based treatment)

Where it fits in real-life diabetes care

Many clinical guidelines position metformin as a common first-line medication for type 2 diabetes (with lifestyle changes). If A1C goals aren’t met, additional medications may be added depending on each person’s needs (weight goals, heart/kidney factors, risk of low blood sugar, cost, and tolerability). DPP-4 inhibitors like alogliptin are generally considered one possible add-on optionespecially when avoiding hypoglycemia is important.

Dosing: How Kazano Is Taken

Kazano is typically taken twice daily with food. Food helps reduce stomach-related side effects from metformin (because metformin is helpful, but it can be… let’s say “enthusiastic” about your GI tract at first).

Available strengths

• 12.5 mg alogliptin / 500 mg metformin
• 12.5 mg alogliptin / 1000 mg metformin

How clinicians choose a starting dose

Prescribers typically individualize the starting dose based on:

• Your current diabetes medications (for example, whether you’re already on metformin)
• Your A1C and blood sugar patterns
• Kidney function
• Side effect history (especially metformin stomach intolerance)

“Gradual dose escalation” (aka: why you might not start at the top)

Metformin can cause nausea, stomach upset, and diarrhea, especially early on. Clinicians often increase the dose gradually to improve tolerance. This is the medication version of “don’t sprint on day one and then quit the gym forever.”

Maximum daily amount (general concept)

Because Kazano is taken twice daily, total daily exposure typically equals 25 mg alogliptin and up to 2000 mg metformin depending on the strength prescribed.

Missed dose basics

• If you miss a dose, take it when you rememberunless it’s close to the next dose.
• Don’t double up “to catch up.” Your stomach (and blood sugar) may protest.

Warnings & Precautions (The “Read This, Don’t Skip It” Section)

Boxed warning: Metformin-associated lactic acidosis

Metformin has a boxed warning for lactic acidosis, a rare but serious condition that can occur when metformin accumulates, especially in higher-risk situations. Reported cases have included severe outcomes. Risk increases with factors like:

• Kidney impairment
• Age 65+
• Radiology studies with iodinated contrast
• Surgery or procedures
• Hypoxic states (such as acute heart failure with poor oxygen delivery)
• Excessive alcohol intake
• Hepatic impairment
• Certain interacting drugs (some can increase metformin levels or worsen acid-base balance)

Call for urgent medical evaluation if symptoms suggest lactic acidosis, such as unusual weakness, worsening tiredness, muscle pain, trouble breathing, unusual sleepiness, or unexplained abdominal discomfortespecially if you also feel cold or dizzy.

Kidney function: a big deal for this combo

Kazano has important kidney-related limitations:

• Contraindicated in severe kidney impairment (eGFR < 30 mL/min/1.73 m²).
• Not recommended when eGFR is between 30 and 60 mL/min/1.73 m² because people in this range may require a lower alogliptin dose than what Kazano provides.
• Kidney function is generally checked before starting and monitored over time.

Pancreatitis (inflammation of the pancreas)

Alogliptin has been associated with reports of acute pancreatitis. Seek medical care right away for persistent, severe abdominal pain that may radiate to the back, with or without vomiting. If pancreatitis is suspected, the medication is typically stopped and evaluated.

Heart failure warning (class-related concern)

Some DPP-4 inhibitors have been associated with heart failure risk in certain populations. Clinicians may weigh this risk more carefully if you have a history of heart failure or kidney problems. Call your clinician promptly if you develop symptoms like shortness of breath, swelling in the legs/ankles, rapid weight gain, or unusual fatigue.

Serious allergic reactions and skin reactions

Do not ignore signs of a serious allergic reaction (swelling of face/lips/tongue, difficulty breathing, widespread rash). Rare but important skin issues have also been reported with DPP-4 inhibitors, including bullous pemphigoid (large blisters), which needs medical attention.

Severe joint pain

Severe and disabling joint pain has been reported with DPP-4 inhibitors. It’s not “normal soreness,” and it’s not a “push through it” situationcontact your clinician if it happens.

Liver problems (rare, but noted)

Rare liver problems have been reported. Contact a healthcare professional if you have symptoms such as yellowing of skin/eyes, dark urine, persistent nausea/vomiting, or upper-right abdominal pain.

Low blood sugar (hypoglycemia): usually about the “other” meds

On its own, Kazano has a relatively low risk of causing hypoglycemia. But the risk rises if it’s used with insulin or sulfonylureas (like glipizide). If you’re on those medications too, your prescriber may adjust doses and recommend monitoring.

Vitamin B12 deficiency (metformin-related)

Long-term metformin use has been associated with lowered vitamin B12 levels in some people. If you have symptoms like numbness/tingling, anemia, or unusual fatigue, clinicians may check B12 levels.

Side Effects

Common side effects (often GI-related)

• Diarrhea
• Nausea
• Stomach upset
• Gas
• Headache
• Cold-like symptoms (in some cases)

Practical tip: Taking Kazano with meals and following any gradual dose increases can help reduce stomach side effects. Also, hydration helps. Your digestive system appreciates basic kindness.

Serious side effects: when to get help fast

• Possible lactic acidosis: unusual weakness, severe fatigue, muscle pain, trouble breathing, worsening sleepiness, abdominal discomfort
• Possible pancreatitis: severe belly pain that doesn’t quit
• Possible heart failure symptoms: shortness of breath, swelling, sudden weight gain
• Severe allergic reaction: facial swelling, difficulty breathing, widespread rash
• Serious skin blistering: large blisters or severe rash

Interactions: What to Avoid (or at Least Discuss)

Alcohol

Excess alcohol increases the risk of lactic acidosis with metformin. If you drink, talk with your clinician about what “safe” looks like for youbecause “occasionally” means different things to different people, and your liver deserves clarity.

Iodinated contrast imaging

Metformin may need to be temporarily stopped around certain imaging studies using iodinated contrast, particularly in people with reduced kidney function or other risk factors. Kidney function is typically rechecked after the procedure before restarting.

Other diabetes medications

Insulin and sulfonylureas can increase the risk of low blood sugar when combined with Kazano. Dose adjustments and monitoring may be needed.

Drugs that may increase metformin levels or lactic acidosis risk

Some medications can impair kidney function or affect acid-base balance. One often-discussed example category includes carbonic anhydrase inhibitors (such as topiramate) that can increase acidosis risk. Always share your full medication list, including supplements.

“Silent” interactions: dehydration and acute illness

Not a classic drug interaction, but still important: severe vomiting/diarrhea, dehydration, or serious infection can increase lactic acidosis risk. Some clinicians give “sick day rules” for metformin-containing medsask your prescriber what they recommend.

Pictures: What Does Kazano Look Like?

Tablet appearance can vary by strength and manufacturer. A safe way to identify your medication is to use:

• The imprint code on the tablet
• The exact strength printed on your prescription label
• A pharmacist or a reputable pill identifier tool

Important: Don’t rely on color alone. Plenty of pills are the same color. Pharmacy shelves are basically a beige-and-white optical illusion.

How to Take Kazano More Comfortably (and Consistently)

Build the habit

• Pair doses with regular meals (breakfast + dinner is common).
• Use a phone reminder until it becomes automatic.
• Keep backup doses only if your clinician/pharmacist approves safe storage and you can track expiration.

Monitoring that usually matters

• A1C every few months (frequency depends on your situation)
• Kidney function (eGFR) before starting and periodically
• Vitamin B12 in long-term use or if symptoms arise
• Blood sugar logs if you’re adjusting therapy or have hypoglycemia risk

Frequently Asked Questions

Will Kazano cause weight gain?

Metformin is often weight-neutral and sometimes associated with modest weight loss. DPP-4 inhibitors are generally weight-neutral. Individual results vary, and lifestyle factors still matter.

Is Kazano safe in pregnancy?

Diabetes management in pregnancy is specialized. If you are pregnant or planning pregnancy, talk with a clinician promptlymedication choices may change, and tight glucose control is important.

Can I take it if I have kidney disease?

Kidney function is a key deciding factor. Kazano is contraindicated with eGFR < 30 and not recommended in eGFR 30–60 due to fixed-dose limitations. Your clinician will choose a safer plan based on labs.

What if I feel sick and can’t keep food down?

Because dehydration and acute illness can raise risk with metformin-containing meds, contact your clinician for guidance. Don’t “power through” severe illness without medical advice.

Real-World Experiences (What People Commonly Run Into)

Note: The experiences below reflect common, real-world patterns reported in clinical practice and patient educationshared here as educational scenarios, not as medical advice or personal testimony.

1) “The first two weeks were… a digestive negotiation.”

A lot of people’s earliest experience with metformin-containing medications is gastrointestinal. It’s not glamorous, but it’s common: loose stools, stomach rumbling, mild nausea, and a general sense that your gut is holding a meeting without inviting you. The people who do best usually do a few practical things: take doses with meals, avoid skipping meals (then taking a pill “on an empty stomach” as a surprise event), and stick with a gradual titration plan if their clinician recommends it. Many report that symptoms improve over days to weeks once their body adjusts. The key is distinguishing “annoying but improving” from “intense and not improving,” which should be discussed with a clinician.

2) “My numbers got better, but I didn’t feel a dramatic ‘kick in.’”

Unlike some medications where you can feel an immediate effect, many diabetes medications work quietly in the background. People often notice improvements when they check their glucose readings, or when an A1C comes back lower at a follow-up appointment. That can feel anticlimacticlike you trained for a marathon and your medal is a lab printout. But it’s also a sign the medication is doing what it’s supposed to do: improving glucose control without making you feel jittery or “crashed.”

3) “I didn’t realize my ‘other meds’ mattered so much.”

A very common learning moment is realizing how much the full medication list matters. Someone might start Kazano and feel fineuntil a new medication is added (or they start a supplement) and suddenly things feel off. Another classic: combining therapy with insulin or a sulfonylurea can raise low-blood-sugar risk, even if Kazano itself isn’t usually the main culprit. People often describe that as confusing at first: “But I didn’t change my eating!” This is where a quick check-in with a prescriber helps, because the fix may be adjusting the dose of the other glucose-lowering medication rather than stopping everything.

4) “I had a scan with contrast and no one mentioned my diabetes meds.”

Contrast imaging can be a real-world tripwire for metformin-containing medications. Patients sometimes report learning about metformin/contrast precautions after the factoften from a pharmacist or a pre-procedure checklist. The practical takeaway many people adopt is: whenever a scan is scheduled, they proactively ask, “Will this use iodinated contrast, and do I need medication instructions for metformin?” That one question can prevent confusion and reduce risk, especially for those with lower kidney function or other risk factors.

5) “I started paying attention to hydration and sick days.”

Another common experience is developing a plan for “sick days.” People who have had a rough bout of stomach flu (vomiting/diarrhea) often become more aware of dehydration risk and the importance of contacting a clinician when they can’t keep fluids down. In real life, it’s not unusual for someone to say, “I thought it was just a bug, but my care team wanted me to pause certain meds temporarily.” The point isn’t to self-manage without guidanceit’s to have a clear playbook from your clinician so you don’t have to guess when you’re already feeling miserable.

6) “The best change wasn’t the pillit was the routine.”

Many patients say the biggest improvement came from linking medication with a sustainable routine: consistent meals, a repeatable movement plan, and simple tracking. The medication supports the biology, but habits support the consistency. People often describe small wins: fewer extreme highs, less post-meal spiking, fewer “I’m starving at 10 p.m.” moments after balancing protein and fiber. Kazano can be part of that stability, but it usually works best when the overall system (food, activity, sleep, monitoring, follow-ups) becomes less chaotic.

Conclusion

Kazano (alogliptin/metformin) is designed for adults with type 2 diabetes who need a two-medication approach in one tablet. It can help improve blood sugar and A1Cespecially when paired with diet, activity, and regular monitoring. But it’s not a casual medication: kidney function matters a lot, and the metformin component carries a rare but serious lactic acidosis warning. The best outcomes tend to come from a partnership approachclear dosing instructions, lab monitoring, and a plan for procedures, contrast scans, and sick days.

If you’re prescribed Kazano, your most powerful tools aren’t just the tabletsthey’re the questions you ask: “How will we monitor kidney function?” “What should I do if I get dehydrated or sick?” and “How does this fit with my other diabetes meds?” Ask those, and you’ll avoid a lot of preventable surprises.